Introduction
Azadine is a prescription medication that contains the active ingredient Azacitidine. It is available in the injectable form and is used for the treatment of certain types of blood disorders.
Uses
Azadine is primarily prescribed for the treatment of myelodysplastic syndrome (MDS), a group of blood disorders characterized by abnormal production of blood cells in the bone marrow. It is also used in the treatment of acute myeloid leukemia (AML) in patients who are not suitable for standard chemotherapy.
Dosage and Administration
The dosage of Azadine will be determined by your healthcare provider based on your specific condition and medical history. It is administered as an injection into the subcutaneous tissue (under the skin) or into a vein, depending on your healthcare provider’s instructions. The injection is usually given daily for several days or weeks, followed by a rest period. The exact dosing schedule will be determined by your healthcare provider.
Mechanism of Action
Azacitidine, the active ingredient in Azadine, works by inhibiting the DNA methylation process. Methylation is a chemical modification that can regulate gene expression. By inhibiting this process, Azacitidine helps to restore normal gene expression patterns, which may help in the treatment of blood disorders.
Side Effects
Common side effects may include nausea, vomiting, diarrhea, fatigue, and injection site reactions. Notify your healthcare provider if these side effects persist or worsen.
Serious side effects may occur, although they are rare. These can include bone marrow suppression (reduced production of blood cells), liver problems, and kidney problems. If you experience any signs of these serious side effects, such as persistent fever, unusual bleeding or bruising, yellowing of the skin or eyes, or changes in urine output, seek immediate medical attention.
Drug Interactions
inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Certain medications may interact with Azadine, potentially affecting its effectiveness or increasing the risk of side effects. Your healthcare provider will assess any potential drug interactions and adjust your treatment plan accordingly.
Precautions
Before starting treatment with Azadine, inform your healthcare provider about any allergies you may have, as well as your medical history, including any previous or current infections, liver problems, or kidney problems. This medication may not be suitable for everyone, and your healthcare provider will assess the potential risks and benefits before prescribing it.
Azadine should not be used during pregnancy unless specifically prescribed by your healthcare provider. Use effective contraception during treatment and for a certain period afterwards, as this medication may harm an unborn baby.
Storage
Azadine should be stored in a refrigerator between 2°C and 8°C (36°F and 46°F). Do not freeze the medication. Keep it away from light and moisture. Keep it out of the reach of children.
Patient Tips
- Follow your healthcare provider’s instructions regarding the dosage and administration of Azadine.
- Keep all scheduled appointments with your healthcare provider for monitoring and follow-up.
- Report any side effects or concerns to your healthcare provider.
- Store the medication properly in the refrigerator and protect it from light and moisture.
- If you miss a dose, contact your healthcare provider for further instructions. Do not double the dose to make up for a missed one.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Azacitidine 25 mg/ml powder for suspension for injection (Health Professionals SmPC) Available at:
- Azacitidine (Drugs.com) [Accessed 13 Jun. 2024] (online) Available at:
- azacitidine 300 mg tablet (RX) [Accessed 16 Jun. 2024] (online) Available at:
- Azacitidine (MedlinePlus) [Accessed 26 Jun. 2024] (online) Available at:
- [No authors listed] Azacitidine. IARC Monogr Eval Carcinog Risks Hum. 1990;50:47-63. [Accessed 16 Jun. 2024] Available at:
Reviews
There are no reviews yet.